MENU

ADXS Ayala Pharmaceuticals, Inc. Forecast, Technical & Fundamental Analysis

Ayala Pharmaceuticals Inc is a clinical-stage oncology company whose primary clinical assets currently include aspacytarabine (BST-236), a novel proprietary anti-metabolite for first-line treatment in unfit acute myeloid leukemia (AML)... Show more

Industry: #Biotechnology
Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of immunotherapies for cancer and infectious diseases

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
Oppenheimer 4
Phone
+972 8574440553
Employees
35
Web
https://www.ayalapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.770.79
+3.59%
GameStop Corp
TSLA366.208.12
+2.27%
Tesla
AAPL337.004.59
+1.38%
Apple
SPY762.608.55
+1.13%
State Street® SPDR® S&P 500® ETF
BTC.X76403.770000253.453120
+0.33%
Bitcoin cryptocurrency
Ayala Pharmaceuticals (ADXS) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com